NASDAQ: ZLAB
Zai Lab Ltd Stock Forecast, Predictions & Price Target

Analyst price target for ZLAB

Based on 3 analysts offering 12 month price targets for Zai Lab Ltd

Min Forecast
$36.10+15.26%
Avg Forecast
$47.37+51.24%
Max Forecast
$55.00+75.61%

Should I buy or sell ZLAB stock?

Based on 3 analysts offering ratings for Zai Lab Ltd.

Buy
Strong Buy
1 analysts 33.33%
Buy
1 analysts 33.33%
Hold
1 analysts 33.33%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Our proven Zen Rating quant model agrees with analyst consensus with a "Buy" rating. Learn More

Be the first to know when Wall Street analysts revise their ZLAB stock forecasts and price targets.

ZLAB stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-03-13
lockedlocked$00.00+00.00%2025-03-07
lockedlocked$00.00+00.00%2025-03-03

1 of 1

Forecast return on equity

Is ZLAB forecast to generate an efficient return?

Company
56.19%
Industry
83.24%
Market
67.01%
ZLAB's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is ZLAB forecast to generate an efficient return on assets?

Company
38.83%
Industry
23.68%
ZLAB is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ZLAB earnings per share forecast

What is ZLAB's earnings per share in the next 3 years based on estimates from 5 analysts?

Avg 1 year Forecast
-$1.29
Avg 2 year Forecast
-$0.36
Avg 3 year Forecast
$0.42

ZLAB revenue forecast

What is ZLAB's revenue in the next 3 years based on estimates from 4 analysts?

Avg 1 year Forecast
$561.6M+34.25%
Avg 2 year Forecast
$771.2M+84.36%
Avg 3 year Forecast
$1.1B+158.69%
ZLAB's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

ZLAB revenue growth forecast

How is ZLAB forecast to perform vs Biotechnology companies and vs the US market?

Company
38.3%
Industry
138.45%
Market
9.82%
ZLAB's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ZLAB's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ZLAB vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ZLAB$31.32$47.37+51.24%Buy
RARE$35.66$109.25+206.37%Strong Buy
SWTX$46.48$55.00+18.33%Hold
ACLX$63.92$106.75+67.01%Strong Buy
CRSP$36.86$70.62+91.58%Buy

Zai Lab Stock Forecast FAQ

Is Zai Lab Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: ZLAB) stock is to Buy ZLAB stock.

Out of 3 analysts, 1 (33.33%) are recommending ZLAB as a Strong Buy, 1 (33.33%) are recommending ZLAB as a Buy, 1 (33.33%) are recommending ZLAB as a Hold, 0 (0%) are recommending ZLAB as a Sell, and 0 (0%) are recommending ZLAB as a Strong Sell.

If you're new to stock investing, here's how to buy Zai Lab stock.

What is ZLAB's earnings growth forecast for 2025-2027?

(NASDAQ: ZLAB) Zai Lab's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 12.56%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 19.91%.

Zai Lab's earnings in 2025 is -$252,070,000.On average, 5 Wall Street analysts forecast ZLAB's earnings for 2025 to be -$1,403,658,555, with the lowest ZLAB earnings forecast at -$1,670,505,544, and the highest ZLAB earnings forecast at -$889,489,965. On average, 4 Wall Street analysts forecast ZLAB's earnings for 2026 to be -$385,084,070, with the lowest ZLAB earnings forecast at -$1,052,201,544, and the highest ZLAB earnings forecast at $314,575,719.

In 2027, ZLAB is forecast to generate $455,592,421 in earnings, with the lowest earnings forecast at $455,592,421 and the highest earnings forecast at $455,592,421.

What is ZLAB's revenue growth forecast for 2025-2027?

(NASDAQ: ZLAB) Zai Lab's forecast annual revenue growth rate of 38.3% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 138.45%, and while it is forecast to beat the US market's average forecast revenue growth rate of 9.82%.

Zai Lab's revenue in 2025 is $418,326,000.On average, 4 Wall Street analysts forecast ZLAB's revenue for 2025 to be $609,217,100,885, with the lowest ZLAB revenue forecast at $604,202,330,020, and the highest ZLAB revenue forecast at $613,639,601,602. On average, 4 Wall Street analysts forecast ZLAB's revenue for 2026 to be $836,582,668,172, with the lowest ZLAB revenue forecast at $775,591,859,900, and the highest ZLAB revenue forecast at $909,449,252,224.

In 2027, ZLAB is forecast to generate $1,173,856,652,843 in revenue, with the lowest revenue forecast at $1,162,661,011,464 and the highest revenue forecast at $1,185,052,294,222.

What is ZLAB's forecast return on assets (ROA) for 2025-2027?

(NASDAQ: ZLAB) forecast ROA is 38.83%, which is higher than the forecast US Biotechnology industry average of 23.68%.

What is ZLAB's Price Target?

According to 3 Wall Street analysts that have issued a 1 year ZLAB price target, the average ZLAB price target is $47.37, with the highest ZLAB stock price forecast at $55.00 and the lowest ZLAB stock price forecast at $36.10.

On average, Wall Street analysts predict that Zai Lab's share price could reach $47.37 by Mar 13, 2026. The average Zai Lab stock price prediction forecasts a potential upside of 51.24% from the current ZLAB share price of $31.32.

What is ZLAB's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: ZLAB) Zai Lab's current Earnings Per Share (EPS) is -$2.40. On average, analysts forecast that ZLAB's EPS will be -$1.29 for 2025, with the lowest EPS forecast at -$1.54, and the highest EPS forecast at -$0.82. On average, analysts forecast that ZLAB's EPS will be -$0.36 for 2026, with the lowest EPS forecast at -$0.97, and the highest EPS forecast at $0.29. In 2027, ZLAB's EPS is forecast to hit $0.42 (min: $0.42, max: $0.42).

What is ZLAB's forecast return on equity (ROE) for 2025-2027?

(NASDAQ: ZLAB) forecast ROE is 56.19%, which is considered strong.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.